GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Andros Pharmaceuticals Co 6917.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

30.75

+3.19%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 5.5m

FY2020FY2025

Net income

−TWD 53.8m

FY2020FY2025

Free cash flow

−TWD 46.4m

FY2020FY2025

Shareholders' equity

TWD 515.7m

FY2020FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020
RevenueTWD 5.5mTWD 203,000TWD 805,000TWD 1.7mTWD 13.3mTWD 3.3m
Gross profitTWD 1.8mTWD 10,000TWD 313,000TWD 966,000TWD 8.6mTWD 2.4m
Research and developmentTWD 58.2mTWD 71.8mTWD 56.9mTWD 35.6mTWD 32.5mTWD 36.3m
Operating income−TWD 75.6m−TWD 89.6m−TWD 73.7m−TWD 40.7m−TWD 36.6m−TWD 42.4m
Net income−TWD 53.8m−TWD 78.3m−TWD 68.2m−TWD 41.2m−TWD 37.1m−TWD 35.9m
Diluted earnings per share-1.15-1.70-1.46-0.88-0.79-0.77

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020
Total assetsTWD 559.0mTWD 441.5mTWD 529.1mTWD 329.6mTWD 120.3mTWD 153.3m
Cash and short-term investments—TWD 353.0mTWD 442.6mTWD 254.7mTWD 67.7mTWD 92.7m
Total liabilitiesTWD 43.3mTWD 47.3mTWD 58.0mTWD 50.1mTWD 51.6mTWD 63.0m
Debt—TWD 22.0mTWD 27.1mTWD 31.3mTWD 34.6mTWD 38.8m
Shareholders' equityTWD 515.7mTWD 394.2mTWD 471.1mTWD 279.5mTWD 68.7mTWD 90.4m
Shares outstanding47m46m47m47m47m47m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020
Cash from operations−TWD 45.4m−TWD 78.9m−TWD 46.6m−TWD 35.8m−TWD 35.9m−TWD 26.7m
Capital spending−TWD 990,000−TWD 4.5m−TWD 582,000−TWD 46,000—−TWD 2.1m
Free cash flow−TWD 46.4m−TWD 83.4m−TWD 47.2m−TWD 35.8m−TWD 35.9m−TWD 28.8m

Latest quarters

By quarter end

Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022Jun 2022Dec 2021
RevenueTWD 64,000TWD 129,000TWD 74,000TWD 343,000TWD 462,000TWD 676,000TWD 1.0mTWD 2.5m
Gross profitTWD 2,000−TWD 7,000TWD 17,000TWD 176,000TWD 137,000TWD 457,000TWD 509,000TWD 612,000
Operating income−TWD 40.3m−TWD 51.5m−TWD 38.1m−TWD 46.9m−TWD 26.8m−TWD 24.4m−TWD 22.4m−TWD 21.0m
Net income−TWD 46.2m−TWD 45.9m−TWD 32.3m−TWD 43.7m−TWD 24.4m−TWD 22.2m−TWD 19.0m−TWD 20.8m
Diluted earnings per share-1.00-0.99-0.70-1.22-0.69-0.79-0.53-0.58
Total assetsTWD 395.9mTWD 441.5mTWD 480.2mTWD 529.1mTWD 301.7mTWD 329.6mTWD 233.8mTWD 120.3m
Cash and short-term investments—TWD 353.0mTWD 397.9mTWD 442.6mTWD 217.0mTWD 254.7mTWD 181.4mTWD 67.7m
Debt—TWD 5.2mTWD 5.1mTWD 5.1mTWD 5.1mTWD 4.8mTWD 28.8mTWD 29.9m
Shareholders' equityTWD 357.4mTWD 394.2mTWD 438.1mTWD 471.1mTWD 255.1mTWD 279.5mTWD 184.3mTWD 68.7m

Financial ratios

Data as of 4 Nov 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Gross margin32.4%4.9%38.9%56.4%64.6%72.7%—
Operating margin-959.9%-38306.9%-8409.6%-2376.6%-275.0%-1080.2%—
Net margin-969.3%-38561.1%-8467.0%-2403.7%-278.9%-1098.1%—
Return on equity-10.4%-19.9%-14.5%-14.7%-54.1%-39.7%—
Return on assets-9.6%-17.7%-12.9%-12.5%-30.9%-23.4%—
Free cash flow yield-3.0%-5.1%—————
Revenue growth2633.0%-74.8%-53.0%-87.1%307.4%——
Earnings growth-31.3%14.8%65.5%10.9%3.5%——
Current ratio13.97x13.81x14.16x13.62x4.42x4.24x—
Debt to equity—0.01x0.01x0.02x0.07x0.05x0.04x
Equity ratio92.3%89.3%89.0%84.8%57.1%58.9%—
Interest coverage-196.51x-228.04x-153.86x-87.74x-73.22x-63.15x—
R&D as a share of sales1048.6%35348.8%7063.5%2076.7%244.4%1111.1%—
Buybacks as a share of market value-1.3%——————

Growth per year

Compound annual rate

3 years5 years10 years
Revenue48.0%11.2%—
Operating income22.9%12.3%—
Net income9.3%8.4%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin31.5%37.4%56.6%—
Operating margin-2873.3%-3382.1%-1443.5%—
Net margin-2296.2%-2919.2%-1265.2%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023
Price to earnings-21.1-10.1-17.1
Price to sales204.9——

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.